Crescendo Bioscience, Myriad Settle Blood Test Kickback Suit (2)

Crescendo Bioscience Inc., Myriad Genetics Inc., and a whistleblower settled a False Claims Act suit alleging that the companies engaged in kickback schemes involving a blood test to defraud Medicare and Medicaid, the parties told a California district court.

The parties filed a stipulation of voluntary dismissal Monday with the U.S. District Court for the Northern District of California.

Crescendo and Myriad will pay $45.25 million to the U.S. government and California under the settlement, according to a document provided by counsel for whistleblower STF LLC.

“The settlement contains no admission of liability, wrongdoing or responsibility on the part of ...